V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008470 | 310005634 | 1.77 | null | Not known (9) | 2016-04-06 | 2016-04-28 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | N | Y | 310024207 | CHOEP |
| 310008471 | 310005636 | 1.85 | 60 | Curative (C) | null | 2018-02-01 | Irinotecan + Modified De Gramont | N | N | 310024263 | NIVOLUMAB |
| 310008472 | 310008509 | 1.72 | null | Curative (C) | 2015-02-21 | 2016-02-13 | METHOTREXATE | 2 | null | 310024307 | NIVOLUMAB |
| 310008473 | 310005641 | null | 78.6 | null | 2014-02-07 | 2014-03-24 | Triple Intrathecal | N | null | 310024340 | METHOTREXATE HIGH DOSE |
| 310008474 | 310008511 | 1.64 | 40.1 | Curative (C) | 2016-12-22 | 2017-01-05 | Trabectedin | N | N | 310024417 | CARBOPLATIN + DOCETAXEL |
| 310008475 | 310005644 | null | 54.1 | null | 2014-01-17 | 2014-05-10 | Azacitidine | N | N | 310024447 | TRASTUZUMAB |
| 310008476 | 310008512 | 1.59 | 52 | Palliative (P) | 2016-11-13 | 2017-05-10 | CVD | 02 | N | 310024470 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 310008477 | 310005646 | 1.83 | 76.8 | Adjuvant (A) | 2018-02-08 | 2018-02-08 | NIVOLUMAB | 02 | null | 310024565 | METHOTREXATE |
| 310008478 | 310010873 | 1.7 | 67.6 | Curative (C) | 2015-11-08 | 2016-04-23 | IVAC | 2 | N | 310024614 | CAPECITABINE + IRINOTECAN |
| 310008479 | 310011348 | 1.6 | null | Palliative (P) | 2018-10-24 | 2018-10-24 | Dacarbazine | N | N | 310024614 | GEMCITABINE + OXALIPLATIN |
| 310008480 | 310005649 | null | 65.8 | Palliative (P) | 2017-12-11 | 2017-12-18 | ECX | 02 | null | 310024693 | CAPECITABINE |
| 310008481 | 310005650 | 1.65 | 71 | Palliative (P) | 2015-01-31 | 2015-02-01 | Temozolomide 200mg/m2 | 02 | N | 310024822 | TRABECTEDIN |
| 310008482 | 310005652 | null | 0 | Curative (C) | 2018-01-01 | 2018-01-17 | CARBOPLATIN + ETOPOSIDE + THIOTEPA | N | N | 310024857 | BENDAMUSTINE |
| 310008483 | 310005653 | 1.74 | 52 | Not known (9) | 2017-09-23 | 2017-10-03 | Bendamustine + prednisolone | N | N | 310024859 | PEG INTERFERON |
| 310008484 | 310005654 | null | null | Disease modification (D) | 2018-08-04 | 2018-08-04 | CVP | N | N | 310024978 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 310008485 | 310005655 | 1.75 | 58.6 | Palliative (P) | 2016-02-03 | 2016-02-04 | ICE + GCSF | 02 | N | 310024978 | VINBLASTINE |
| 310008486 | 310005656 | 1.67 | 74 | Palliative (P) | 2018-11-24 | 2018-11-25 | Vinblastine | 02 | N | 310025026 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310008487 | 310005658 | null | 59.3 | null | 2014-08-14 | 2014-09-04 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 310025101 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310008488 | 310005661 | null | null | Disease modification (D) | 2013-11-02 | 2013-11-30 | IMATINIB | N | N | 310025185 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310008489 | 310005661 | 1.8 | 61.9 | Curative (C) | 2016-04-09 | 2016-04-09 | Pentostatin | Y | N | 310025185 | CARBOPLATIN + RT |
| 310008490 | 310010043 | null | 69.3 | Palliative (P) | 2017-08-08 | 2018-07-04 | DA-EPOCH-R | N | null | 310025220 | CAPECITABINE + OXALIPLATIN |
| 310008491 | 310010043 | 1.54 | 70.3 | null | 2018-03-07 | 2018-03-24 | Azacitidine | null | N | 310025220 | RCEOP |
| 310008492 | 310010043 | null | 85.6 | Palliative (P) | 2017-02-26 | 2017-02-27 | Methotrexate High Dose (3g/m2) | N | N | 310025220 | PEG INTERFERON |
| 310008493 | 310005662 | 1.73 | 120 | Neo-adjuvant (N) | 2018-01-25 | 2018-02-05 | Lenalidomide Cycle 26 onwards (PAS) | N | N | 310025400 | METHOTREXATE |
| 310008494 | 310005665 | 0 | 0 | Palliative (P) | 2015-08-28 | 2015-08-30 | BEAM + FLUDARABINE | 2 | N | 310025418 | VINBLASTINE |
| 310008495 | 310005666 | null | 73 | Palliative (P) | 2013-09-13 | 2013-09-16 | Atezolizumab | N | N | 310025461 | CAPECITABINE + OXALIPLATIN |
| 310008496 | 310005667 | 1.57 | 97 | Palliative (P) | 2017-03-26 | 2017-07-18 | Trabectedin | 02 | N | 310025467 | CARBOPLATIN + PEMETREXED |
| 310008497 | 310008525 | 1.62 | 78.7 | Curative (C) | 2018-07-16 | 2018-08-01 | R-GEM-P | null | null | 310025467 | CHLORAMBUCIL |
| 310008498 | 310005672 | 1.57 | null | Palliative (P) | 2018-10-21 | 2018-10-24 | Trabectedin | null | null | 310025486 | DACARBAZINE + GEMCITABINE |
| 310008499 | 310010047 | 1.61 | 83 | Palliative (P) | 2017-03-13 | 2017-03-17 | MITOMYCIN | null | N | 310025531 | TRABECTEDIN |
| 310008500 | 310005675 | 1.61 | 46.7 | Neo-adjuvant (N) | 2016-12-16 | 2017-02-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 310025657 | OXALIPLATIN + MDG |
| 310008501 | 310005676 | 1.55 | 57 | Curative (C) | 2017-01-28 | 2017-01-28 | Hydroxycarbamide | 02 | N | 310025663 | BCG |
| 310008502 | 310005677 | null | 75 | Palliative (P) | 2017-03-09 | 2017-03-10 | CODOX M | N | null | 310025697 | CYTARABINE HD + METHOTREXATE HD |
| 310008503 | 310005678 | 1.59 | 49 | Palliative (P) | 2015-03-29 | 2015-04-07 | FLUOROURACIL + OXALIPLATIN | 02 | N | 310025707 | MELPHALAN + TOPOTECAN |
| 310008504 | 310005680 | 1.62 | 0 | Palliative (P) | 2014-06-09 | 2014-06-24 | Capecitabine + Cisplatin | N | N | 310025747 | CARBOPLATIN + DOCETAXEL |
| 310008505 | 310005681 | 1.53 | 23.1 | Palliative (P) | 2017-08-02 | 2017-08-09 | NEOSCOPE TRIAL | N | N | 310025747 | ICE |
| 310008506 | 310005681 | 1.76 | 42.2 | Curative (C) | 2018-10-03 | 2018-10-03 | ICON8B TRIAL | 02 | N | 310025747 | FLUDARABINE + MELPHALAN |
| 310008507 | 310005681 | 1.74 | 109.9 | Curative (C) | 2016-05-27 | 2016-05-27 | Sunitinib | N | N | 310025747 | CTD |
| 310008508 | 310011350 | 1.48 | null | Palliative (P) | 2018-03-01 | 2018-03-01 | FEC 100 | N | N | 310001814 | RUXOLITINIB |
| 310008509 | 310005682 | null | 66 | Curative (C) | 2018-01-21 | 2018-01-24 | ICE-R (Cycle 2 onwards) | null | N | 310001900 | CAPECITABINE + CISPLATIN |
| 310008510 | 310005684 | 1.67 | 50.45 | Curative (C) | 2017-10-08 | 2018-01-28 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | Y | null | 310002058 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310008511 | 310005684 | 1.43 | 54.1 | Palliative (P) | 2018-11-28 | 2018-11-29 | TOPOTECAN | 02 | N | 310002058 | TOPOTECAN |
| 310008512 | 310005684 | 0 | 53.8 | Palliative (P) | 2019-05-11 | 2019-05-15 | NIVOLUMAB | 2 | N | 310002058 | DACARBAZINE |
| 310008513 | 310005685 | 1.65 | 78.4 | Palliative (P) | 2015-05-12 | 2015-05-13 | TRASTUZUMAB | 02 | Y | 310002603 | IMATINIB |
| 310008514 | 310005686 | 1.64 | 76 | Curative (C) | 2019-11-30 | 2019-12-13 | CVP R | 2 | N | 310002637 | OXALIPLATIN + MDG |
| 310008515 | 310005690 | 1.62 | null | Palliative (P) | 2018-05-12 | 2018-05-25 | ICON8 TRIAL | N | N | 310002667 | ALEMTUZUMAB |
| 310008516 | 310008534 | null | 73 | Curative (C) | null | 2018-09-16 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 310003186 | RMS 2005 TRIAL |
| 310008517 | 310008534 | 1.78 | 62 | c | 2017-05-03 | 2017-05-15 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 310003186 | METHOTREXATE |
| 310008518 | 310005691 | 1.78 | 0 | Palliative (P) | 2015-12-17 | 2015-12-18 | CVD | Y | N | 310003466 | ETOPOSIDE + MELPHALAN |
| 310008519 | 310005692 | null | 10.7 | Palliative (P) | 2016-03-20 | 2016-03-20 | ECX | 2 | N | 310003513 | LANREOTIDE |